SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

VOR

Vor Biopharma Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 13h ago SEC0000315066-26-002877
Passive stake amendment
Actionable Insight • Neutral

Fidelity's passive stake is unchanged at 10.7%. No signal of increased conviction or exit. Monitor next filing for any change in position or conversion to 13D.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$18.66
T+0 close · Nov 5, 2026 · via day close
Latest settled
+3.54%
T+5 · $19.32
Vs SPY
+0.25%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $18.66entry
  2. T+1 · 11d ago +6.54%α +6.23% · $19.88
  3. T+5 · 5d ago +3.54%α +0.25% · $19.32
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 6,318,525 shares of Vor Biopharma common stock as of September 30, 2026, representing 10.7% of shares outstanding. This is an increase from the prior filing (6,318,525 shares vs. 6,318,525 shares at July 31, 2026), the stake is unchanged. Fidelity remains a passive holder above the 5% threshold.

Key Financial Metrics

Stake
10.7%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC (Fidelity) reported beneficial ownership of 6,318,525 shares of Vor Biopharma common stock as of September 30, 2026.
  • The stake represents 10.7% of shares outstanding.
  • This is an amendment to Schedule 13G, confirming passive investment intent.
  • The stake is unchanged from the prior filing (6,318,525 shares as of July 31, 2026).
  • Fidelity Management & Research Company LLC is the entity beneficially owning 5% or greater.

Financial Impact

Stake valued at approximately $128.4M based on $1.2B market cap and 10.7% ownership.

ownership_percentage

Risk Factors

  • Fidelity could reduce its stake in future periods, potentially pressuring the stock.
  • Passive filing status means no activist intent is signaled.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002877
Document: 0000315066-26-002877-index-headers.html0000315066-26-002877
Document: 0000315066-26-002877-index.html0000315066-26-002877
Document: 0000315066-26-002877.txt0000315066-26-002877

Track record

17 reports on VOR

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +70.35% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.97 Now $18.97 −0.00% settles Nov 18
  2. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.32 to $19.42 Now $18.97 −1.81% ▲ +0.52% +0.88% vs SPY
  3. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $18.66 to $19.88 Now $18.97 +1.66% ▲ +6.54% +6.23% vs SPY
  4. Oct 30, 202617d ago 424B5 Bearish 4/10 Entry $19.68 to $19.25 Now $18.97 +3.61% ▲ +2.19% +1.71% vs SPY
  5. Oct 30, 202617d ago Press Release Neutral 4/10 Entry $19.68 to $19.25 Now $18.97 −3.61% ▼ −2.19% −1.71% vs SPY
  6. Oct 22, 202625d ago Press Release Bullish 7/10 Entry $18.26 to $18.33 Now $18.97 +3.89% ▲ +0.38% −0.33% vs SPY
  7. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $18.31 to $18.78 Now $18.97 +3.60% ▲ +2.57% +2.81% vs SPY
  8. Sep 29, 20266w ago Press Release Bullish 6/10 Entry $18.33 to $19.08 Now $18.97 +3.49% ▲ +4.09% +4.30% vs SPY
  9. Aug 11, 202613w ago Press Release Neutral 3/10 Entry $23.37 to $22.34 Now $18.97 −18.83% ▼ −4.41% −4.66% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Entry $19.14 to $18.03 Now $18.97 −0.89% ▼ −5.80% −5.03% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026